• Webinar
    #Cannabis ASX:AGH

    Althea CBD products to become available over the counter under proposed TGA reclassification

    Australian pharmaceutical company Althea Group Holdings Limited (ASX:AGH)(‘Althea’ or ‘the Company’)is pleased to invite shareholders and investors to a briefing with CEO JoshuaFegan to discuss the interim decision to down schedule cannabidiol (CBD) released yesterday.
    September 11
    5 months ago
    Watch
    • 263 < Discover more events
    Interested in the ASX listed companies in this event? Check out the latest news, announcements, financial data, and capital raise history for: